February 3-7, 2024
Boston Convention and Exhibition Center
Boston, MA, USA
February 3-7, 2024
Boston Convention and Exhibition Center
Boston, MA, USA
This course will provide current standards and considered best practice in the discipline of sample management. It will focus on the traditional aspects of compound management (including how to maintain and measure quality of compounds). Recognizing the importance of biologics in drug discovery, the course will also cover biological reagents and best practice in biobanking and clinical sample management.
Susan Crimmin, Ph.D.
Sue Crimmin, Ph.D., is currently running her own consulting firm focusing on sample management, logistics, automation and new technology. Sue is the current treasurer of SLAS and sits on the SLAS Board of Directors. She recently retired form her role as VP of Discovery Supply at GlaxoSmithKline. She is a recognized industry expert in sample management and automation and has worked in areas of automation, sample management, HTS and IT. Crimin holds a Ph.D. in microbial biochemistry and is a trained Lean Sigma facilitator.
Katheryn Shea
Azenta Life Sciences
Kathi Shea is the Senior Director of Repository Innovation at Azenta Life Sciences. She is a former President of the International Society for Biological and Environmental Repositories (ISBER) and an active member of several ISBER committees and working groups. Shea served on the Advisory Working Group that developed the College of American Pathologists Biorepository Accreditation Program and is an active member of the CAP BAP Committee. She has over 20 years of experience leading biorepository programs and advising on the design of biorepositories, quality systems, and optimal methods for collection, preservation and annotation of biospecimen collections.